Amitiza and Angiopathy - a phase IV clinical study of FDA data

Summary:

Angiopathy is reported as a side effect among people who take Amitiza (lubiprostone), especially for people who are female, 50-59 old, also take Lipitor, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Angiopathy when taking Amitiza. It is created by eHealthMe based on reports of 10,225 people who have side effects when taking Amitiza from the FDA, and is updated regularly.

What is Amitiza?

Amitiza has active ingredients of lubiprostone. It is often used in constipation. eHealthMe is studying from 10,567 Amitiza users. Check the latest studies of Amitiza.

What is Angiopathy?

Angiopathy (generic term for a disease of the blood vessels) is found to be associated with 721 drugs and 874 conditions by eHealthMe. Check the latest studies of Angiopathy.

On Jul, 17, 2026

10,225 people reported to have side effects when taking Amitiza.
Among them, 23 people (0.22%) have Angiopathy.

Among these 23 people:

What is the gender of people who have Angiopathy when taking Amitiza? *

female: 100 %
male: 0.0 %

What is the age of people who have Angiopathy when taking Amitiza? *

What are other drugs people take besides Amitiza? *

What are other side effects people have besides Angiopathy? *

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 23 people, 100.00%
Pain In Jaw: 23 people, 100.00%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 23 people, 100.00%
Purulent Discharge (discharge that contains pus): 23 people, 100.00%
Mitral Valve Prolapse (heart's mitral valve doesn't work well): 23 people, 100.00%
Itching: 23 people, 100.00%
Paraesthesia Oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect): 23 people, 100.00%
Eczema Asteatotic (severe dry skin- during the winter months and in the elderly): 23 people, 100.00%
Pain: 23 people, 100.00%
High Blood Pressure: 23 people, 100.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 23 people, 100.00%
High Blood Pressure: 21 people, 91.30%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 21 people, 91.30%
Fatigue (feeling of tiredness): 21 people, 91.30%

* Approximation only. Some reports may have incomplete information.

Do you take Amitiza and have Angiopathy?

- Check whether Angiopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amitiza:

Amitiza (10,567 reports)

Angiopathy treatments and more:

Angiopathy (8,773 reports)

Browse all side effects of Amitiza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Angiopathy:

Angiopathy (721 drugs)

Browse all the conditions that are associated with Angiopathy:

Angiopathy (874 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lubiprostone (the active ingredients of Amitiza) and Amitiza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.